X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

PTPI

Closed

Petros Pharmaceuticals Inc

0.0325
-0.0015 (-4.41%)
Last Update: 01 Jul 2025 21:29:00
Yesterday: 0.034
Day's Range: 0.0325 - 0.0385
Send
When Written:
 
0.99
Petros Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing innovative therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, PET-CT01, is a novel, small molecule inhibitor of the enzyme phosphoribosyl pyrophosphate synthetase (PRPS), which is overexpressed in many types of cancer. PET-CT01 has shown promising results in preclinical studies, and the company is currently conducting a Phase 1 clinical trial in patients with advanced solid tumors.

Petros Pharmaceuticals was founded in 2018 and is headquartered in Durham, North Carolina. The company is led by a team of experienced biotech executives and has partnerships with leading academic institutions and research organizations. Petros Pharmaceuticals is backed by top-tier venture capital firms, including Hatteras Venture Partners, 5AM Ventures, and RA Capital Management.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X